Effect of amorphous silica nanoparticles on in vitro rankl-induced osteoclast differentiation in murine macrophages

Nanoscale Research Letters

Volumn 6, Issue , 2011, Pages 1-5

  Nabeshi, Hiromi ^a,b   Yoshikawa, Tomoaki ^a,b   Akase, Takanori ^a,b   Yoshida, Tokuyuki ^a,b   Tochigi, Saeko ^a,b   Hirai, Toshiro ^a,b   Uji, Miyuki ^a,b   Ichihashi, Ko ichi ^a,b   Yamashita, Takuya ^a,b   Higashisaka, Kazuma ^a,b   Morishita, Yuki ^a,b   Nagano, Kazuya ^b   Abe, Yasuhiro ^b   Kamada, Haruhiko ^a,b   Tsunoda, Shin ichi ^a,b   Itoh, Norio ^a,b   Yoshioka, Yasuo ^a,b   Tsutsumi, Yasuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Nanoparticle; Osteoclast differentiation; Silicon dioxide

Indexed keywords

AMORPHOUS SILICA; CYTOTOXIC EFFECTS; IN-VITRO; MACROPHAGE CELLS; MULTINUCLEATED CELLS; MURINE MACROPHAGES; NANO-SILICA; NUCLEAR FACTORS; ORAL CARE; OSTEOCLAST CELLS; OSTEOCLAST DIFFERENTIATION; POLISHING AGENTS; RECEPTOR ACTIVATOR; REMINERALIZATION; SILICA PARTICLES; SUBMICRON-SIZED; TARTRATE-RESISTANT ACID PHOSPHATASE;

CYTOTOXICITY; MACROPHAGES; NANOPARTICLES; PHOSPHATASES;

SILICA;

MURINAE;

EID: 84856026818     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/1556-276X-6-464     Document Type: Article

References (20)

1. Gaikwad RM, Sokolov I: Silica nanoparticles to polish tooth surfaces for caries prevention. J Dent Res 2008, 87:980-983.
2. Liao WQ, Zang YL, Shao JZ: Sporotrichosis presenting as pyoderma gangrenosum. Mycopathologia 1991, 116:165-168.
3. Napierska D, Thomassen LC, Lison D, Martens JA, Hoet PH: The nanosilica hazard: another variable entity. Part Fibre Toxicol 2010, 7:39.
4. Yamashita K, Yoshioka Y, Higashisaka K, Mimura K, Morishita Y, Nozaki M, Yoshida T, Ogura T, Nabeshi H, Nagano K, Abe Y, Kamada H, Monobe Y, Imazawa T, Aoshima H, Shishido K, Kawai Y, Mayumi T, Tsunoda SI, Itoh N, Yoshikawa T, Yanagihara I, Saito S, Tsutsumi Y: Nat Nanotechnol 2011.
5. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdörster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB: Safe handling of nanotechnology. Nature 2006, 444:267-269.
6. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Matsuo K, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Nakagawa S, Mayumi T, Tsunoda S, Tsutsumi Y: Systemic distribution, nuclear entry and cytotoxicity of amorphous nanosilica following topical application. Biomaterials 2011, 32:2713-2724.
7. Ash P, Loutit JF, Townsend KM: Osteoclasts derived from haematopoietic stem cells. Nature 1980, 283:669-670.
8. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ: Modulation of osteoclast differentiation and function by new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999, 20:345-357.
9. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR, Armstrong A, Shen V, Bain S, Cosman D, Anderson D, Morrissey PJ, Peschon JJ, Schuh J: RANK is essential for osteoclast and lymph node development. Genes Dev 1999, 13:2412-2424.
10. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW, Ahmed-Ansari A, Sell KW, Pollard JW, Stanley ER: Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci USA 1990, 87:4828-4832.
11. Yoshida H, Hayashi S, Kunisada T, Ogawa M, Nishikawa S, Okamura H, Sudo T, Shultz LD: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990, 345:442-444.
12. Takayanagi H: Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304.
13. Teitelbaum SL, Ross FP: Genetic regulation of osteoclast development and function. Nat Rev Genet 2003, 4:638-649.
14. Theill LE, Boyle WJ, Penninger JM: RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002, 20:795-823.
15. Nabeshi H, Yoshikawa T, Matsuyama K, Nakazato Y, Arimori A, Isobe M, Tochigi S, Kondoh S, Hirai T, Akase T, Yamashita T, Yamashita K, Yoshida T, Nagano K, Abe Y, Yoshioka Y, Kamada H, Imazawa T, Itoh N, Tsunoda S, Tsutsumi Y: Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 2010, 65:199-201.
16. Clohisy JC, Frazier E, Hirayama T, Abu-Amer Y: RANKL is an essential cytokine mediator of polymethylmethacrylate particle-induced osteoclastogenesis. J Orthop Res 2003, 21:202-212.
17. Pioletti DP, Kottelat A: The influence of wear particles in the expression of osteoclastogenesis factors by osteoblasts. Biomaterials 2004, 25:5803-5808.
18. Tautzenberger A, Kreja L, Zeller A, Lorenz S, Schrezenmeier H, Mailänder V, Landfester K, Ignatius A: Direct and indirect effects of functionalized fluorescence-labelled nanoparticles on human osteoclast formation and activity. Biomaterials 2010, 32:1706-1714.
19. Hillaireau H, Couvreur P: Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66:2873-2896.
20. Muller WE, Boreiko A, Wang X, Krasko A, Geurtsen W, Custodio MR, Winkler T, Lukic-Bilela L, Link T, Schroder HC: Morphogenetic activity of silica and bio-silica on the expression of genes controlling biomineralization using SAOS-2 cells. Calcif Tissue Int 2007, 81:382-393.